Completed PHASE1 INTERVENTIONAL 2-arm NCT00500695

Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Schizoaffective Disorder Schizophrenia

Interventions Motivational Interviewing Psychoeducation

Updated 6 times since 2017 Last updated: Jul 13, 2017 Started: May 31, 2006 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Schizoaffective Disorder and Schizophrenia, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 6 data snapshots since 2006. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Aug 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Aug 2017 [monthly]

Completed PHASE1

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
Rutgers, The State University of New Jersey

Data source: Rutgers, The State University of New Jersey

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Brunswick, United States